Get a clear overview of all current promotions and deals from our suppliers.
Can’t find a product in our catalog, or need a fully custom solution? We’ve got you covered.
Looking for specific products, alternatives, documentation or any other assistance? We’re here to help.
Connect with us in person, and let us connect you to the right products and suppliers for your research.
Discover how FiberCell Systems’ 3D hollow fiber bioreactors revolutionize exosome production, delivering high-quality, serum-free EVs for cutting-edge research and therapeutic applications.
Are you looking to revolutionize your B cell expansion protocols for clinical research and immunotherapies? Look no further than B-Xpander™ by AdipoGen Life Sciences.
Leukemia, a blood and bone marrow cancer, impacts millions of lives worldwide and remains a major health crisis. Despite medical advancements, managing this awful disease continues to be a challenge.
The very first NordiQC assessment of DB Biotech P16 (clone R15-A) and they passed it with distinction!
Bio X Cell offers the most published and extensive selection of Anti-Mouse and Anti-Human CTLA-4 antibodies, including recombinant antibodies and Biosimilars, for your in vivo and in vitro pre-clinical research.
AdipoGen Life Sciences developed new Fc-based fusion proteins using the Knobs-into-Holes technology. These InVivoKines™ show enhanced activity & stability for immunotherapeutic and preclinical in vivo research.
Bio X Cell offers the most published and extensive selection of Anti-Mouse and Anti-Human PD-1 antibodies, including recombinant antibodies and Biosimilars, for your in vivo and in vitro pre-clinical research.
Last month Bio-Connect attended the 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) in Rotterdam.
The Cancer Cell Culture toolbox consists of three functional media that can be used individually, or in all possible combinations – just pick what suits your workflow.
TargetMol diligently updates and offers over 800 types of compound libraries, covering various popular diseases/fields, such as cancer/tumor, immunity & inflammation, infectious diseases,
organoids and stem cells, etc.
Cancer, a dynamic disease with diverse variations within and across individuals. Understanding its complexity shows the need for personalized diagnosis and treatment, moving beyond one-size-fits-all approaches.
A CE-IVD marked diagnostic tool which screens for 28 chromosomal translocations associated with Leukemia.
AMPIVIEW™ RNA probes are uniquely designed with the precision of targeted, sequence specific RNA probes, powered by Enzo’s LoopRNA ISH™ technology to deliver superior sensitivity.
To support innovation in the ever-evolving landscape of immuno-oncology, BPS Bioscience offers a suite of NK Cell research solutions from ready-to-use primary cells and expansion kits to functional bioassays.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where excessive fat accumulates in liver cells.
Atlas Antibodies: Explore how CD markers advance cancer research, providing critical insights into cell populations and disease prognosis.
GeneTex employs a state-of-the-art production platform and enhanced validation strategies to create reliable and inexhaustible IHC-validated recombinant monoclonal antibodies for cancer research.
Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay has been approved by BSI and the EMA as a Class C CDx assay.
ABclonal offers high quality free samples to test in specific application or tissue type. Their free samples covers research fields including cancer, cell biology, epigenetics, immunology, metabolism, and neuroscience.
PromoCell has developed a cancer cell culture portfolio that covers a complete range of applications for culturing human cancer cells.
Cell Guidance Systems launches two new products: Instant Exosomes™, a range of well characterized freeze-dried exosomes and LipoQ™, a lipid quantification assay
LSBio continues to expand its collection of breast cancer immunohistochemistry (IHC) marker antibodies, offering IHC-Plus™ antibodies rigorously validated for IHC applications on FFPE human tissues.
Ovarian cancer is the deadliest form of cancer in the female reproductive system. Atlas Antibodies has released novel monoclonal antibodies with diagnostic and prognostic value in ovarian cancers.
The advent of second-generation neuroendocrine neoplasms (NENs) markers for use in IHC has considerably expanded the pathology toolbox. Atlas Antibodies has released new monoclonal markers targeting NENs.
The identification and validation of biomarkers in cancer is essential to improve our understanding of the disease.
The brain is the most fascinating and intriguing organ of the human body. Multiplexing immunohistochemistry allows a comprehensive study of cell composition, cellular functions, and cell‐cell interactions.
Atlas Antibodies continuously updates its antibody portfolio with highly validated antibodies for use in glioma research.
GeneTex reagents have been cited for more than 20,000 times.
T-Cure Biosciences and Atlas Antibodies have entered a collaboration agreement for the development, manufacture and supply of CT83 (KK-LC-1) monoclonal antibodies for diagnostic use.
Targeting cancer stem cells is a therapeutic strategy that holds hope for the improvement of patients’ survival.
We gladly support you by keeping you updated on our latest products and developments
